Glioma

1 paper

In silico1

Trial sponsors

Eli Lilly and Company
Company1 trialPhase 1200 people
NewLink Genetics Corporation
Company1 trialPhase 181 people
Leiden University Medical Center
1 trialPhase 4120 people
Tanta University
1 trialPhase 375 people
National Cancer Institute
2 trialsPhase 26,495 people
Dana-Farber Cancer Institute
1 trialPhase 223 people
University of Alabama at Birmingham
1 trialPhase 223 people
Washington University School of Medicine
1 trialPhase 26 people

Latest

2 in 12 months

bioRxiv31 Aug

Glioblastoma Tumors with Decelerated Epigenetic Aging Are Characterized by Glutamatergic Neuronal Activity and Stemness

Preprint: study in peopleInterventions

Frontiers in Immunology6 Aug

Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework

Computational studyMechanisms